JSPR vs. MO

Last updated Jun 23, 2026

JSPR (Jasper Therapeutics, Inc.) and MO (Altria Group, Inc.) are both stocks. JSPR operates in Biotechnology (Healthcare), while MO operates in Tobacco (Consumer Defensive). Over the past 3 years, JSPR returned -65.95%/yr vs 26.24%/yr for MO. At a correlation of -0.06, they often move in opposite directions.

Performance

JSPR vs. MO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Jasper Therapeutics, Inc. (JSPR) and Altria Group, Inc. (MO). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, JSPR achieves a -72.60% return, which is significantly lower than MO's 24.40% return.

JSPR

• 1D: 10.71%
• 1M: -44.46%
• YTD: -72.60%
• 6M: -73.74%
• 1Y: -90.26%
• 3Y*: -65.95%
• 5Y*: —
• 10Y*: —

MO

• 1D: 0.56%
• 1M: -4.53%
• YTD: 24.40%
• 6M: 24.63%
• 1Y: 24.23%
• 3Y*: 26.24%
• 5Y*: 16.82%
• 10Y*: 7.44%

*Multi-year figures are annualized to reflect compound growth (CAGR)

JSPR vs. MO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
JSPR Jasper Therapeutics, Inc.	-72.60%	-91.44%	170.98%	63.39%	-93.85%	-37.90%
MO Altria Group, Inc.	24.40%	18.17%	40.76%	-3.70%	4.37%	-1.04%

Correlation

The correlation between JSPR and MO is -0.16, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.16
Correlation (3Y) Calculated over the trailing 3-year period	-0.12
Correlation (All Time) Calculated using the full available price history since Sep 24, 2021	-0.06

Fundamentals

Market Cap JSPR : $14.38M MO : $116.29B
EPS JSPR : -$2.87 MO : $4.79
Total Revenue (TTM) JSPR : $0.00 MO : $21.82B
Gross Profit (TTM) JSPR : -$290.00K MO : $14.80B
EBITDA (TTM) JSPR : -$72.26M MO : $11.70B

Return for Risk

JSPR vs. MO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

JSPR

JSPR Risk / Return Rank: 6
JSPR Sharpe Ratio Rank: 8
JSPR Sortino Ratio Rank: 3
JSPR Omega Ratio Rank: 2
JSPR Calmar Ratio Rank: 3
JSPR Martin Ratio Rank: 14

MO

MO Risk / Return Rank: 70
MO Sharpe Ratio Rank: 74
MO Sortino Ratio Rank: 67
MO Omega Ratio Rank: 68
MO Calmar Ratio Rank: 69
MO Martin Ratio Rank: 71

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

JSPR vs. MO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Jasper Therapeutics, Inc. (JSPR) and Altria Group, Inc. (MO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	JSPR	MO	Difference
Sharpe ratio: Return per unit of total volatility	-0.85	1.07	-1.92
Sortino ratio: Return per unit of downside risk	-1.88	1.54	-3.41
Omega ratio: Gain probability vs. loss probability	0.73	1.21	-0.48
Calmar ratio: Return relative to maximum drawdown	-0.97	1.48	-2.45
Martin ratio: Return relative to average drawdown	-1.23	3.71	-4.94

JSPR vs. MO - Sharpe Ratio Comparison

The current JSPR Sharpe Ratio is -0.85, which is lower than the MO Sharpe Ratio of 1.07. The chart below compares the historical Sharpe Ratios of JSPR and MO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

JSPR vs. MO - Drawdown Comparison

The maximum JSPR drawdown since its inception was -99.72%, which is greater than MO's maximum drawdown of -65.43%. Use the drawdown chart below to compare losses from any high point for JSPR and MO.

Drawdown Indicators

	JSPR	MO	Difference
Max Drawdown Largest peak-to-trough decline	-99.72%	-65.43%	-34.29%
Max Drawdown (1Y) Largest decline over 1 year	-93.37%	-16.40%	-76.97%
Max Drawdown (3Y) Largest decline over 3 years	-98.49%	-16.40%	-82.09%
Max Drawdown (5Y) Largest decline over 5 years	—	-25.83%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-53.69%	—
Current Drawdown Current decline from peak	-99.69%	-5.37%	-94.32%
Average Drawdown Average peak-to-trough decline	-88.49%	-11.92%	-76.57%
Ulcer Index Depth and duration of drawdowns from previous peaks	73.29%	6.55%	+66.74%

Volatility

JSPR vs. MO - Volatility Comparison

Jasper Therapeutics, Inc. (JSPR) has a higher volatility of 48.15% compared to Altria Group, Inc. (MO) at 6.94%. This indicates that JSPR's price experiences larger fluctuations and is considered to be riskier than MO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	JSPR	MO	Difference
Volatility (1M) Calculated over the trailing 1-month period	48.15%	6.94%	+41.21%
Volatility (6M) Calculated over the trailing 6-month period	76.45%	17.83%	+58.62%
Volatility (1Y) Calculated over the trailing 1-year period	106.07%	22.80%	+83.27%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	241.69%	20.68%	+221.01%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	241.69%	23.00%	+218.69%

Dividends

JSPR vs. MO - Dividend Comparison

JSPR has not paid dividends to shareholders, while MO's dividend yield for the trailing twelve months is around 6.10%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
JSPR Jasper Therapeutics, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
MO Altria Group, Inc.	6.10%	7.21%	7.65%	9.52%	8.05%	7.43%	8.29%	6.57%	6.07%	3.56%	3.48%	3.73%

Financials

Frequently Asked Questions

Can I hold both JSPR and MO in my portfolio?

JSPR and MO have a correlation of -0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, JSPR or MO?

JSPR has higher volatility (48.15%) compared to MO (6.94%). In terms of maximum drawdown, JSPR dropped -99.72% vs MO's -65.43%.

Which has better risk-adjusted returns?

MO currently has the higher Sharpe Ratio (1.07 vs -0.85), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.